loading...

International Prostate Symptom Score (I-PSS)

Barry MJ

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

  • Created from the American Urologic Association Symptom Index (AUA-SI).
  • The I-PSS includes the 7 original items (AUA-SI) + an additional QOL question.
  • The present page focuses on the IPSS-1 (original version developed by Barry MJ et al. 1992).
Authors

Barry MJ

Copyright
Public domain.
To reproduce the instrument in a publication, permission of the Journal of Urology is required.
Objective
To capture the severity of urinary symptoms related to benign prostatic hyperplasia
Therapeutic area
  • Male Urogenital Diseases
Therapeutic indication

Benign Prostatic Hyperplasia

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the UK
  • English for the USA
English for the USA for the IPSS-1 version
English for the UK for the IPSS-2 version
Bibliographic reference(s) of the original questionnaire

Barry MJ, Fowler FJ, O'leary MP et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. Journal of Urology 1992;148:1549-1557

Access this questionnaire

Distribution of Translations

Existing translations can be obtained from Mapi Research Trust. 

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.


Contact and conditions of use

Authors

Barry MJ

Medical Practices Evaluation Center
Massachusetts General Hospital
50 Stanford St., 9th floor
Boston, MA 02114
USA
Phone: +1 (617) 726-4106
Fax: +1 (617) 726-4120
E-mail: mbarry@partners.org

Michael J Barry Publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Distribution of Translations

Existing translations can be obtained from Mapi Research Trust. 

Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the UK
  • English for the USA
English for the USA for the IPSS-1 version
English for the UK for the IPSS-2 version

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

I-PSS 1 (Acute version)

Afrikaans for South Africa*
Chinese for Singapore*
Chinese for Taiwan*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for South Africa*
Estonian for Estonia*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
German for Germany*
Greek for Greece*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Kannada for India*
Latvian for Latvia*
Lithuanian for Lithuania*
Malay for Singapore*
Marathi for India*
Norwegian for Norway*
Polish for Poland*
Romanian for Romania*
Russian for Latvia*
Russian for Russia*
Russian for Ukraine*
Slovak for Slovakia*
Spanish for Argentina*
Spanish for Chile*
Spanish for Colombia*
Spanish for Mexico*
Spanish for Spain*
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden*
Ukrainian for Ukraine*

I-PSS 1 (Standard version)

Afrikaans for South Africa*
Chinese for Singapore*
Chinese for Taiwan*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for South Africa*
Finnish for Finland*
French for Belgium*
French for Canada*
French for France*
German for Austria*
German for Germany*
Greek*
Greek for Greece*
Hebrew*
Hebrew for Israel*
Hungarian for Hungary*
Italian for Italy*
Korean for Korea*
Lithuanian for Lithuania*
Mandarin for Taiwan*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Romanian for Romania*
Russian for Russia*
Russian for Ukraine*
Slovak for Slovakia*
Spanish for Argentina*
Spanish for Mexico*
Spanish for Spain*
Spanish for the USA*
Swedish for Finland*
Swedish for Sweden*
Turkish for Turkey*
Ukrainian for Ukraine*
Urdu for Pakistan

I-PSS 2 (Standard version)

Afrikaans for South Africa
Arabic for Egypt*
Bulgarian for Bulgaria*
Chinese for Taiwan*
Croatian for Croatia*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)
Dutch for the Netherlands*
English for Australia
English for Canada
English for New Zealand*
English for South Africa
Estonian for Estonia*
Filipino for the Philippines*
Finnish for Finland*
French for Belgium
French for Canada
French for France*
French for Switzerland
German for Austria*
German for Germany*
German for Switzerland
Greek for Greece*
Hebrew for Israel*
Hungarian for Hungary*
Icelandic for Iceland*
Italian for Italy*
Italian for Switzerland
Japanese for Japan*
Korean for Korea*
Latvian for Latvia*
Lithuanian for Lithuania*
Mandarin for Taiwan*
Mandarin for the USA*
Norwegian for Norway*
Polish for Poland
Portuguese for Brazil*
Portuguese for Portugal*
Romanian for Romania*
Russian for Russia
Serbian for Serbia*
Slovak for Slovakia*
Slovenian for Slovenia*
Spanish for Argentina*
Spanish for Chile*
Spanish for Colombia*
Spanish for Mexico*
Spanish for Puerto Rico*
Spanish for Spain*
Spanish for the USA
Swedish for Sweden
Thai for Thailand*
Turkish for Turkey*
Ukrainian for Ukraine*
* Performed by Mapi

I-PSS 2: "Mandarin for the USA" refers to Mandarin Chinese for San Francisco

BiblioPRO: you can find information about the Spanish version here - puede encontrar información sobre la versión española aqui

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Please submit a request online to sign a translation agreement:

  1. Log in or Register for free
  2. Submit your request online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will get back to you with the needed information in a timely manner

More information on translations

Bibliographic reference for the Danish, Dutch, Dutch for Belgium, French, French for Canada, German, Italian, Norwegian, Spanish, and Swedish translations:

Badia X, Garcia-Losa M, Dal-Re R. Ten-language Translation and Harmonisation of the International Prostate Symptom Score: Developing a Methodology for Multinational Clinical Trials. European Urology 1997;31:129-140 (PubMed abstract)

Bibliographic reference for the Japanese translation:

Homma Y, Tsukamoto T, Yasuda K et al. [Linguistic validation of Japanese version of International Prostate Symptom Score and BPH impact index] Nippon Hinyokika Gakkai Zasshi.2002 Sep; 93(6) : 669-80. Japanese (Full text article)

Bibliographic reference for the Turkish translation:

Bozlu M, Doruk E, Akbay E, Ulusoy E, Cayan S, Acar D, Kanik EA. Effect of administration mode (patient vs physician) and patient's educational level on the Turkish version of the International Prostate Symptom Score. Int J Urol. 2002 Aug; 9(8):417-21 (Full text article)

Bibliographic reference for the Urdu (Pakistan) translation:

Salman M, Khan AH, Sulaiman SA, Hughes J, Khan JH, Hussain K. The Modified Urdu version of International Prostate Symptom Score: A psychometric validation study. Turkish journal of urology. 2018 Jul;44(4):335-40 (Full text article)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us